NetworkNewsWire

NetworkNewsWire

TechMediaBreaks – Cepton Inc. (NASDAQ: CPTN) Adds Greater Flexibility, Accelerated Technology Development Capability to NVIDIA Omniverse Platform
Cepton (NASDAQ:CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently integrated its Vista-X120 Plus lidar into DRIVE Sim, an end-to-end simulation application built on the NVIDIA
TinyGemsBreaks – Lexaria Bioscience Corp.'s (NASDAQ: LEXX) DehydraTECH(TM)-Processed Formulation Results in Higher Concentration, Delivery of Estrogen Hormone than Control
Lexaria Bioscience Corp. (NASDAQ:LEXX), a global innovator in drug delivery platforms, recently completed its animal study HOR-A22-1, which showed that the company's patented DehydraTECH(TM) technology platform
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well Positioned to Move next NanoAb Candidates into Clinical Application
BiondVax (NASDAQ:BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently
InvestorNewsBreaks – GolfLync Inc. Affirms Status as Go-to 'Social Network for Golfers'
GolfLync is the company behind the GolfLync app – a social network for matching golf games and players. "GolfLync just affirmed its status as the go-to ‘social network for golfers' with over 200
Team Managing Bankrupt FTX Announces Recovery of Nearly $7B in Assets
The FTX bankruptcy team has recently published a comprehensive report that delves deep into the financial intricacies of the collapsed exchange. According to their findings, a sizable debt of $8.6 billion was owed
Three in Five Americans Support Psychedelic Therapy Legalization, Poll Finds
A recent poll by UC Berkeley's Center for the Science of Psychedelics (BCSP) has revealed that a majority of Americans are in favor of legalizing psychedelic therapy. The first-ever poll of its kind, the UC
Russian Crisis Concerns Cause Gold to Stabilize Above Quarterly Low
Gold has seen a modest increase in price as more investment flowed into the safe haven metal amid concerns about the political turbulence in Russia. The precious metal has been a safe haven asset for
America, EU Opt for Differing Approaches to China-Made EVs
The perception of Chinese automakers has quickly evolved from that of low-grade imitations to that of serious competitors to Western manufacturers. The country's local market surpasses all others: China sold 27
InvestorNewsBreaks – The BuildClub Announces Plans to Host Q&A Webinar
The BuildClub, the on-demand marketplace for building materials that is transforming the construction industry with an AI-driven approach, has scheduled a key webinar. The event, which is scheduled for July 12, 2023, at
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Advancing the Use of AI to Power Financial Solutions
Fintech Ecosystem Development (NASDAQ:FEXD), a special purpose acquisition company ("SPAC"), is pushing the conversation around the use of artificial intelligence ("AI") to power financial solutions, and for a good
InvestorNewsBreaks – MetaWorks Platforms Inc. (CSE: MWRK) (OTCQB: MWRK) Inks Agreement to Acquire Assets of ChatGPT-Powered Metaverse Platform
MetaWorks Platforms (CSE:MWRK) (OTCQB:MWRK), an award-winning Web3 company that owns and operates platforms in the entertainment and technology space, has signed a definitive agreement to acquire the Metaverse platform
Research Maps Neighborhoods of Psoriasis Cells in Attempt to Understand Condition
Researchers are leveraging new mapping techniques to study psoriasis cells to understand the condition better. Psoriasis occurs when the immune system becomes overactive and causes inflammation in the skin,
InvestorNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Announces Closing of $24.5M Debt Refinancing
Eat Well Group (CSE:EWG) (OTC:EWGFF), a leading plant-based food agribusiness and CPG company, has successfully closed a refinancing effort announced late last year. The company worked with the Business Development
InvestorNewsBreaks – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) Reports 2023 Annual General and Special Meeting Voting Results
Exro Technologies (TSX:EXRO) (OTCQB:EXROF), a leading clean-technology company that develops new-generation power-control electronics that expand the capabilities of electric motors and batteries, recently held its
Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Control North America's REE Supply Chain Amid Call For Economically and Environmentally Sound Approach
Ucore Rare Metals (TSX.V: UCU) (OTCQX:UURAF), a company with a vision and plan to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Offering to Include Boutique End-to-End CDMO Services
BiondVax Pharmaceuticals (NASDAQ:BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune
420 with CNW — NFL to Inject More Dollars into Studying Cannabis as Concussion Treatment
The joint efforts of the National Football League (NFL) and its players' union have resulted in the announcement of a new round of funding for independent research on the therapeutic advantages of CBD as an
420 with CNW — Congress Passes Spending Bill Extending Blockage of Adult-Use Cannabis in D.C.
Washington D.C. residents won't be purchasing recreational cannabis any time soon after Congressional lawmakers extended a ban on adult-use marijuana sales in the region. Although residents voted in favor of
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Published Peer-Reviewed Article on DehydraTECH(TM)-CBD, Bringing Publication Total to Eight
Lexaria Bioscience (NASDAQ:LEXX), a global innovator in drug delivery platforms, recently announced the publishing of its groundbreaking research utilizing DehydraTECH(TM)-processed cannabidiol (DehydraTECH-CBD) in eight
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Closes on Public Offering Totaling About $8.5M
Panbela Therapeutics (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, has closed on its previously announced public offering.